XML 72 R58.htm IDEA: XBRL DOCUMENT v3.3.1.900
Research, Consulting and Supply Agreements (Details Narrative)
$ in Thousands
1 Months Ended 12 Months Ended
Aug. 06, 2015
Mar. 09, 2015
Dec. 14, 2011
USD ($)
shares
Oct. 02, 2011
Sep. 06, 2011
Jul. 31, 2015
Nov. 30, 2014
USD ($)
Oct. 31, 2014
USD ($)
Dec. 31, 2015
USD ($)
Number
Dec. 31, 2014
USD ($)
Dec. 31, 2013
USD ($)
Second Amended Adviser's Agreement [Member] | Sage Group, Inc. [Member]                      
Description of entity business                

A health care, technology oriented, strategy and transaction advisory firm, to assist the Company in obtaining a strategic alliance in Japan for the use of Ampligen® in treating Chronic Fatigue Syndrome (“CFS”).

   
Agreement term     24 months                
Effective date of agreement     Jun. 15, 2011                
Description of agreement termination    

This Agreement may be terminated by the Company for cause after the Company delivers written notice to Adviser of a failure to perform and such failure is not cured within fifteen (15) days.

               
Monthly adviser's fee     $ 20                
Number of option granted | shares     200,000                
Vesting period     18 months                
Description of exerise price    

Exercise price of 110% of the closing price of the Company Stock on the NYSE Amex on the closing price of the day preceding the execution date of the agreement.

               
Percentage of success fee up to transation $5,000,000 per annum     5.00%                
Fees and expenses                 $ 399 $ 278 $ 337
Fourth Amendment Supply Agreement [Member] | Jubilant Hollister-Stier Laboratories LLC [Member]                      
Description of entity business                

Formulate and package Ampligen® from the key raw materials that Hemispherx would supply to them.

   
Expiration date       Mar. 11, 2014              
Purchase commitment               $ 700      
Commercial Supply Agreement [Member] | Althea Technologies, Inc. [Member]                      
Purchase commitment             $ 622   $ 210    
Marketing, Education & Sales Agreement [Member]                      
Agreement term 5 years                    
Marketing, Education & Sales Agreement [Member] | Armada Healthcare, LLC [Member]                      
Agreement term         3 years            
Expiration date           Aug. 14, 2017          
Distribution Agreement [Member] | BioRidge Pharma, LLC [Member]                      
Agreement term         3 years            
Fees and expenses                 $ 2 21 21
Expiration date           Aug. 14, 2017          
Distribution Agreement [Member] | Emerge Health Pty Ltd [Member]                      
Agreement term   5 years                  
Multi Year [Agreement] | Impatients, N.V [Member]                      
Description of entity business                

Company doing business as myTomorrows, for the commencement and management of an Early Access Program (“EAP”) in Europe and Turkey (the “Territory”) related to Chronic Fatigue Syndrome.

   
Number of vials | Number                 1,200    
Consulting Services Agreement [Member]                      
Consulting service fees                 $ 1,668 $ 1,286 $ 1,769
Consulting Services Agreement [Member] | Minimum [Member]                      
Exercised period                 1 year    
Consulting Services Agreement [Member] | Maximum [Member]                      
Exercised period                 3 years